老虎證券

美股詳情
本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Arbutus Biopharma Corporation

4.46
0.0000
盤後：4.480.0200+0.45%18:01 EDT
成交量：84.12萬
成交額：372.06萬
市值：8.72億
市盈率：-25.51
高：4.48
開：4.41
低：4.35
收：4.46
52周最高：5.10
52周最低：2.71
股本：1.95億
流通股本：1.28億
量比：0.74
換手率：0.66%
股息：- -
股息率：- -
每股收益(TTM):-0.1748
每股收益(LYR):-0.1748
淨資產收益率：-38.52%
總資產收益率：-14.94%
市淨率：11.39
市盈率(LYR):-25.51

資料載入中...

總覽公司新聞資訊公告
2020/08/07

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/08/07

重要事件披露

8-K - Current report
2020/07/24

重要事件披露

8-K - Current report
2020/07/16

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/06/24

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2020/06/01

重要事件披露

8-K - Current report
2020/05/18

重要事件披露

8-K - Current report
2020/05/11

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/05/11

重要事件披露

Current report, items 2.02 and 9.01
2020/03/26

重要事件披露

Current report, items 8.01 and 9.01
2020/03/06

[修訂]年度報告

[Amend] Annual report [Section 13 and 15(d), not S-K Item 405]
2020/03/05

年度報告

Annual report [Section 13 and 15(d), not S-K Item 405]
2020/03/05

重要事件披露

Current report, items 2.02 and 9.01
2020/02/19

重要事件披露

Current report, item 5.02
2020/02/14

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/14

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/14

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/10

重要事件披露

Current report, items 8.01 and 9.01
2020/01/13

重要事件披露

Current report, items 2.02, 8.01, and 9.01
2020/01/08

SEC問詢函

[Cover]Correspondence
更多